Materials in particulate form for tissue engineering. 1. Basic concepts

被引:81
作者
Silva, G. A. [1 ,2 ]
Ducheyne, P. [3 ]
Reis, R. L. [1 ,2 ]
机构
[1] Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal
[2] Univ Minho, Res Grp Biomat Biodegradables Biomimet 3Bs, P-4710057 Braga, Portugal
[3] Univ Penn, Ctr Bioact Mat & Tissue Engn, Philadelphia, PA 19104 USA
关键词
microparticles; nanoparticles; drug delivery; tissue engineering; polymers; ceramics; natural origin;
D O I
10.1002/term.2
中图分类号
Q813 [细胞工程];
学科分类号
摘要
For biomedical applications, materials small in size are growing in importance. In an era where 'nano' is the new trend, micro- and nano-materials are in the forefront of developments. Materials in the particulate form aim to designate systems with a reduced size, such as micro- and nanoparticles. These systems can be produced starting from a diversity of materials, of which polymers are the most used. Similarly, a multitude of methods are used to produce particulate systems, and both materials and methods are critically reviewed here. Among the varied applications that materials in the particulate form can have, drug delivery systems are probably the most prominent, as these have been in the forefront of interest for biomedical applications. The basic concepts pertaining to drug delivery are summarized, and the role of polymers as drug delivery systems conclude this review. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:4 / 24
页数:21
相关论文
共 330 条
[1]   In vitro and in vivo characterization of biodegradable enoxacin microspheres [J].
Abazinge, M ;
Jackson, T ;
Yang, Q ;
Owusu-Ababio, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) :191-194
[2]   Microcomposites of poly (ε-caprolactone) and poly(methyl methacrylate) prepared by suspension polymerization in the presence of poly(ε-caprolactone) macromonomer [J].
Abraham, GA ;
Kesenci, K ;
Fambri, L ;
Migliaresi, C ;
Gallardo, A ;
San Román, J .
MACROMOLECULAR MATERIALS AND ENGINEERING, 2002, 287 (12) :938-945
[3]  
Ain Q, 2002, INT J PHARM, V239, P37, DOI 10.1016/S0378-5173(02)00034-0
[4]   Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics [J].
Allémann, E ;
Leroux, JC ;
Gurny, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :171-189
[5]   Enzymatic degradation of starch based thermoplastic compounds used in protheses [J].
Araújo, MA ;
Cunha, AM ;
Mota, M .
ADVANCED MATERIALS FORUM II, 2004, 455-456 :429-432
[6]   In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads [J].
Arica, B ;
Çalis, S ;
Atilla, P ;
Durlu, NT ;
Çakar, N ;
Kas, HS ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (02) :153-165
[7]   Albumin nanoparticles as carriers for a phosphodiester oligonucleotide [J].
Arnedo, A ;
Espuelas, S ;
Irache, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 244 (1-2) :59-72
[8]   The amount of newly formed bone in sinus grafting procedures depends on tissue depth as well as the type and residual amount of the grafted material [J].
Artzi, Z ;
Kozlovsky, A ;
Nemcovsky, CE ;
Weinreb, M .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2005, 32 (02) :193-199
[9]   USE OF MICROPARTICLES FOR PREPARATIVE LIQUID-CHROMATOGRAPHY [J].
ATTEBERY, JA .
CHROMATOGRAPHIA, 1975, 8 (03) :121-123
[10]   In vitro assessment of the enzymatic degradation of several starch based biomaterials [J].
Azevedo, HS ;
Gama, FM ;
Reis, RL .
BIOMACROMOLECULES, 2003, 4 (06) :1703-1712